During the past decade, CHU Toulouse (Rangueil) Service de Cardiologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU Toulouse (Rangueil) Service de Cardiologie" are "Infective Endocarditis" (2 trials). Many other conditions were trialed in "CHU Toulouse (Rangueil) Service de Cardiologie" in a lesser frequency.

Most popular intervention types in "CHU Toulouse (Rangueil) Service de Cardiologie" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amoxicillin" (1 trials), "Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine" (1 trials), "Conventional IV treatment of streptococci/enterococci IE following European guidelines 2015 including amoxicillin, gentamicin, amicillin, vancomycin, penicillin G, ceftriaxone, netilmicin" (1 trials), "Levofloxacin" (1 trials) and "Rifampicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Toulouse (Rangueil) Service de Cardiologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU Toulouse (Rangueil) Service de Cardiologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CHU Toulouse (Rangueil) Service de Cardiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Toulouse (Rangueil) Service de Cardiologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".